Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Brawn Biotech

Sector: Healthcare | Industry: Drugs & Pharma
R 25.15 -1.30  | -4.91% -42.84% 5.04 7.55
BSE Price: Oct 22, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 22, 2019 25.15 -1.30 -4.91% 27.70 26.45 399 25.15 - 27.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 623 P/B: 0.82 NSE Code:
52-Week Range: R 24.25 - 46.10 Dividend Yield: 0.00% BSE Code: 530207
TTM EPS: R 4.99 Book Value: R 30.64 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Brawn Biotech -33.99 -13.72 -8.38 -42.84 -19.59 32.75 6.12
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 16.84 11.61 11.53
Net Profit 4.00 11.96 55.91
EPS 4.00 11.96 55.91
Book Value 13.45 16.14 13.09
Average
Operating Margin 2.93 3.22 2.87
Net Margin 2.02 2.20 1.87
Return on Networth 16.37 18.79 16.09
Return on Investment 23.03 26.61 23.64
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 15.71 31.60 15.71
Operating Profit 90.49 35.71 90.49
Net Profit 76.07 43.97 76.07
EPS 76.06 43.97 76.06
TTM
Revenue 6.58 20.53 6.58
Operating Profit 10.27 -9.12 10.27
Net Profit 12.30 0.67 12.30
EPS 12.30 0.67 12.30
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Brawn Biotech 7.55 69.47 1.50 2.13 16.37 0.82 5.04
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jan 18, 2016 Brij Raj Gupta  Buy Market 118,050 53.00 62.57
Jan 05, 2010 Brij Raj Gupta  Buy Off Market 100,000 16.10 16.10
Jan 05, 2010 Brij Raj Gupta  Buy Off Market 100,000 16.10 16.10
Fund Houses invested in the stock
Fund Mar-97 Mar-97 Dec-96 Sep-96 Jun-96
Franklin Templeton Mutual Fund 1.500 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Brawn Biotech Ltd.

Address: 4 / 4 B , Asaf Ali Road , I I Floor, Delhi Stock Exchange Building, New Delhi, Delhi - 110002 | Phone: 011-23275208

Email: [email protected]

Website: www.brawnpharma.com

Registrar & Transfer Agent: RCMC Share Registry Pvt Ltd

Address: B-25/1, First Floor, Okhla Industrial Area, Phase 2, New Delhi-110 020, B-25/1, First Floor, Okhla Industrial Area, Phase 2 | Phone: 91-011 26387320 / 21 | Fax: 91-011 26387322

Email: [email protected]

Essential checks
Altman Z-Score
4.49
Piotroski F-Score
6
Modified C-Score
2
5-Years Price to Earnings
5.04
5-Years Price to Book
0.82
Earnings Yield
EBIT / Enterprise value
29.45%
PEG
Price / Earnings to growth ratio
0.13
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59